State of the Art Biomedical Services
CryoLife, Inc. is one of the world’s leading contemporary medical device companies, providing:
Preserved human cardiac and vascular tissues
Surgical adhesives and sealants
Implantable end-stage renal disease hemodialysis access grafts for vascular reconstruction surgeries
Since the Company’s inception in 1984, it is estimated that its products and tissues have been implanted in over 1,000,000 patients worldwide.
Products & Services
BioGlue Surgical Adhesive™
The leading surgical adhesive used in cardiovascular surgery.
AV access solution to reduce catheter dependency.
ProCol® Vascular Bioprosthesis
A natural biological graft derived from a bovine mesenteric vein that provides vascular access for ESRD hemodialysis patients.
Transmyocardial revascularization (TMR) is a clinically proven laser therapy procedure for chronic angina patients.
Aortic and pulmonary homografts for cardiac reconstruction.
Allografts for AV access, peripheral bypass, and infected fields.
News & Events
CryoLife Announces Retirement of Founder and Executive Chairman Steven G. Anderson
April 10, 2015
CryoLife, Inc. (NYSE: CRY), a leading medical device and tissue processing company focused on cardiac and vascular surgery, announced that Steven G. Anderson, 76, Executive Chairman of the Board of Directors, has decided to retire effective immediately. As a result of his retirement, he will step down from all positions with the company and its subsidiaries, including as a member of the Board of Directors and Executive Officer of the company. Pat Mackin, President and CEO, has been appointed as the Chairman of the Board.
CryoLife Appoints Jean Holloway as General Counsel
April 1, 2015
CryoLife, Inc. (NYSE: CRY), a leading medical device and tissue processing company focused on cardiac and vascular surgery, announced today the appointment of Jean F. Holloway to the position of Vice President, General Counsel and Corporate Secretary effective April 1, 2015. Ms. Holloway will report directly to Pat Mackin, President and Chief Executive Officer.